Почетна › Дијабетес тип 2 › Alabama
Клинички испитувања за Дијабетес тип 2 во Alabama
22 студии за Дијабетес тип 2 бараат учесници на локации во Alabama.
Градови во Alabama
Официјален текст на студијата (англиски)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Alabama, Birmingham
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Alabama, Birmingham
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06906640A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Heart Center Research, LLC, Huntsville
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07783802A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Cahaba Research, Inc. - Trussville Location, Birmingham
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07754461EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Pinnacle Research Group, LLC, Anniston
- Eastern Shore Research Group, Fairhope
- Lakeview Clinical Research, Guntersville
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT07064473A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Birmingham Clinical Research, Birmingham
- Cullman Clinical Trials, Cullman
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07282600A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Fairhope
- Research Site, Huntsville
- Research Site, Mobile
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07784270A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Birmingham
- AURORA-2 Clinical Site, Huntsville
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Central Research Associates - Flourish - PPDS, Birmingham
- AES - DRS - Synexus Clinical Research US, Inc. - Birmingham, Birmingham
- AES - DRS - Optimal Research Alabama - Huntsville, Huntsville
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 15.9.2026 · NCT07340320A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Lakeview Clinical Research, Guntersville
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 14.9.2026 · NCT07351058A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Flourish Research, Birmingham
Се регрутираФаза 2
Возраст од 18 до 75 · Сите полови · Ажурирано 11.9.2026 · NCT07668388Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- Apogee Clinical Research, LLC, Huntsville
Се регрутираФаза 2
Возраст од 18 до 80 · Сите полови · Ажурирано 11.9.2026 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Birmingham
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07662213Advancing Diabetes Management for People With Physical Disabilities Optimally Through Primary Care-Based Telehealth (ADDOPT)
- UAB Highlands Hospital/Department of Family and Community Medicine, Birmingham
Се регрутира
Возраст од 18 до 89 · Сите полови · Ажурирано 9.9.2026 · NCT07032844AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Univ of Alabama Birmingham, Birmingham
- Eastern Shore Rsrch Inst, LLC, Fairhope
- Chambliss Clinical Trials, LLC, Montgomery
Се регрутираФаза 3
Возраст 45 и постари · Сите полови · Ажурирано 1.9.2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Birmingham
- Research Site, Daphne
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 31.8.2026 · NCT07662044A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Huntsville
- Research Site, Mobile
- Research Site, Sheffield
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 31.8.2026 · NCT07662109CGM for Management of Type 2 Diabetes in Pregnancy
- University of Alabama at Birmingham, Birmingham
Се регрутира
Возраст од 18 до 50 · Жени · Ажурирано 29.6.2026 · NCT06628453Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Central Research Associates, LLC dba Flourish Research, Birmingham
Се регрутираФаза 2
Возраст од 18 до 70 · Сите полови · Ажурирано 15.6.2026 · NCT07502508DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
- University of Alabama at Birmingham, Birmingham
Се регрутираНабљудувачка студија
Возраст од 8 до 15 · Сите полови · Ажурирано 7.5.2026 · NCT06525259FELLAShip to Better Health
- The Worship Center Cristian Church, Birmingham
Се регрутира
Возраст 18 и постари · Мажи · Ажурирано 22.1.2026 · NCT07220213A Low-Carb Approach to Treat Type 2 Diabetes in Pediatric Patients
- University of Alabama at Birmingham/ Children's of Alabama, Birmingham
Се регрутира
Возраст од 12 до 18 · Сите полови · Ажурирано 8.12.2025 · NCT06902077Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.